WESTLAKE CHEMICAL ($WLK) posted quarterly earnings results for Q2 2026 on Tuesday, August 4th. The company reported earnings of $2.01 per share, beating estimates of $1.79 by $0.22. The company also reported revenue of $3,271,000,000, missing estimates of $3,284,046,623 by $-13,046,623.
You can see Quiver Quantitative's $WLK stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
WESTLAKE CHEMICAL Insider Trading Activity
WESTLAKE CHEMICAL insiders have traded $WLK stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $WLK stock by insiders over the last 6 months:
- MARK STEVEN BENDER (EVP & CFO) has made 0 purchases and 3 sales selling 33,822 shares for an estimated $3,604,033.
- ROBERT F. BUESINGER (EVP, PEM Segment Head) sold 4,000 shares for an estimated $461,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
WESTLAKE CHEMICAL Hedge Fund Activity
We have seen 176 institutional investors add shares of WESTLAKE CHEMICAL stock to their portfolio, and 147 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 2,427,200 shares (-57.5%) from their portfolio in Q1 2026, for an estimated $283,545,504
- CAPITAL WORLD INVESTORS added 2,039,682 shares (+93.9%) to their portfolio in Q1 2026, for an estimated $238,275,651
- FMR LLC added 1,083,630 shares (+473.5%) to their portfolio in Q1 2026, for an estimated $126,589,656
- ORBIS ALLAN GRAY LTD added 906,884 shares (+20.7%) to their portfolio in Q1 2026, for an estimated $105,942,188
- GOLDMAN SACHS GROUP INC added 639,374 shares (+84.8%) to their portfolio in Q1 2026, for an estimated $74,691,670
- THOMPSON SIEGEL & WALMSLEY LLC removed 533,314 shares (-99.4%) from their portfolio in Q1 2026, for an estimated $62,301,741
- CITADEL ADVISORS LLC added 512,283 shares (+252.0%) to their portfolio in Q1 2026, for an estimated $59,844,900
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
WESTLAKE CHEMICAL Analyst Ratings
Wall Street analysts have issued reports on $WLK in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 05/06/2026
To track analyst ratings and price targets for WESTLAKE CHEMICAL, check out Quiver Quantitative's $WLK forecast page.
WESTLAKE CHEMICAL Price Targets
Multiple analysts have issued price targets for $WLK recently. We have seen 11 analysts offer price targets for $WLK in the last 6 months, with a median target of $110.0.
Here are some recent targets:
- Vincent Andrews from Morgan Stanley set a target price of $92.0 on 07/02/2026
- John Roberts from Mizuho set a target price of $88.0 on 07/01/2026
- Matthew DeYoe from B of A Securities set a target price of $85.0 on 06/30/2026
- Patrick Cunningham from Citigroup set a target price of $85.0 on 06/24/2026
- Joshua Spector from UBS set a target price of $117.0 on 06/05/2026
- Jeffrey Zekauskas from JP Morgan set a target price of $90.0 on 05/18/2026
- Arun Viswanathan from RBC Capital set a target price of $130.0 on 05/11/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
